Parkinson's Disease (Drugs) Flashcards
Levodopa
L-DOPA - Parkinson’s Treatment
MOA:
- Enters brain and is converted into Dopamine
–> Replaces deficient Dopamine
Carbidopa
Parkinson’s Treatment
Given in combination Levodopa
MOA:
Prevents L-DOPA being converted into Dopamine in the periphery
–> Increase Dopamine
Entacapone
Parkinson’s Treatment
Given in combination Levodopa
Prevents breakdown of Levodopa by inhibiting COMPT
–> Increase Dopamine
Pramipexole
Dopamine Receptor Agonist
MOA:
- Activates DA Receptors responsible for motor control
–> Controls Symptoms of Parkinson’s DIsease
Selegiline
MAO-B Inhibitor
MOA:
- Prevents Dopamine Degradation by inhibiting MAO-B
Amantidine
Treats Parkinson’s Disease
MOA:
Increases Dopamine Release
Inhibits Amine Uptake
Acts on Dopamine Receptors
Orphenadrine
Muscarinic Receptor Antagonist
- Treats Parkinson’s Disease in patients taking antipsychotics
Enhances Dopamine Release by inhibiting M4 mAchR that normally inhibit dopamine
–> Treats Parkinson’s Disease